Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Registration fees
Hotel
Venue
Helpful info
Travel info
Programme
Abstract Submission
Postgraduate Teaching
Nurse Programme
Hands-on
Information for Presenters
In-person Networking
myUEG Community Area
Learn from Leaders
Mentoring
The UEG Night
Let's Meet
Women in GI Networking
Industry Programme
Industry Exhibition
Industry Symposia
Meet the experts sessions
Innovation Hub
List of Supporters & Exhibitors
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
IBD (Posters)
PILLCAM CROHN'S CAPSULE - THE USE OF A PANENTERIC CAPSULE ENDOSCOPY IN A PORTUGUESE CENTER
IBD (Posters)
et al.
COVID-19 OUTBREAK IMPACTING QUALITY OF LIFE AND SELF-PERCEIVED STRESS IN INFLAMMATORY BOWEL DISEASE
IBD (Posters)
et al.
DIAGNOSTIC AND PROGNOSTIC VALUES OF ANTI-GLYCOPROTEIN 2 ANTIBODIES (GP2A) IN INFLAMMATORY BOWEL DISEASES: RESULTS OF A RETROSPECTIVE MONOCENTRIC COHORT STUDY
IBD (Posters)
et al.
INCREASED RELAPSE RATE AFTER DISCONTINUATION OF IMMUNOMODULATOR MONOTHERAPY BUT NOT AFTER WITHDRAWAL FROM COMBINATION REGIMEN IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
IBD (Posters)
et al.
COMPARISON OF SERUM ADALIMUMAB TROUGH LEVELS IN 40MG WEEKLY VS 80MG EVERY TWO WEEKS INTENSIFICATION REGIMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
IBD (Posters)
et al.
SWITCHING OUT OF CLASS IS THE MOST EFFECTIVE STRATEGY IN IBD PATIENTS WITH IMMUNOGENICITY AGAINST ANTI-TNF ANTIBODIES
IBD (Posters)
et al.
RISK FACTORS FOR POOR POSTOPERATIVE OUTCOME IN PATIENTS WITH CROHN'S DISEASE UNDERGOING ILEOCECAL RESECTION
IBD (Posters)
et al.
PREVALENCE AND PREDICTIVE FACTORS OF FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION
IBD (Posters)
et al.
POST-OPERATIVE COURSE OF CROHN´S DISEASE AFTER ILEOCAECAL RESECTION: RESULTS OF A RETROSPECTIVE MONOCENTRIC COHORT STUDY
IBD (Posters)
et al.
GASTROINTESTINAL TOXICITY DUE TO IMMUNE CHECKPOINT INHIBITORS: CLINIC EXPERIENCE IN A TERTIARY REFERRAL HOSPITAL
IBD (Posters)
et al.
IMPROVEMENT OF QUALITY OF LIFE AND CONTINENCE IN PATIENTS WITH DISTAL ULCERATIVE COLITIS TREATED BY MESALAZINE. QUARTZ STUDY
IBD (Posters)
et al.
SPOSIB SB2 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2: FINAL RESULTS
IBD (Posters)
et al.
INFLIXIMAB RESPONSE IN INFLAMMATORY BOWEL DISEASES IS LINKED TO INTERACTION BETWEEN MUCOSAL MICROBIOTA COMPOSITION AND HOST GENE-EXPRESSION
IBD (Posters)
et al.
INCREASED RISK OF INFLAMMATORY BOWEL DISEASE IN INDIVIDUALS WITH HIV IN BOTH DANISH AND US COHORTS
IBD (Posters)
et al.
COMPLICATIONS AND ADVERSE EFFECTS RELATED TO SURGICAL AND MEDICAL TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A PROSPECTIVELY RECRUITED POPULATION-BASED COHORT
IBD (Posters)
et al.
TREATMENT AND OUTCOME OF ULCERATIVE COLITIS DURING THE FIRST 10 YEARS AFTER DIAGNOSIS IN A PROSPECTIVELY FOLLOWED POPULATION-BASED COHORT
IBD (Posters)
et al.
NEW DIAGNOSTIC CAPABILITIES FOR CROHN´S DISEASE: USE OF FATTY ACID PROFILES OF ERYTHROCYTE MEMBRANES AND BLOOD SERUM
IBD (Posters)
et al.
ASSOCIATION BETWEEN DURATION OF LATEST FLARE BEFORE INDUCTION TREATMENT WITH TOFACITINIB AND EFFICACY OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS
IBD (Posters)
et al.
EFFICACY AND SAFETY OF TOFACITINIB RETREATMENT FOR ULCERATIVE COLITIS AFTER TREATMENT INTERRUPTION: AN UPDATE OF RESULTS FROM THE OCTAVE CLINICAL TRIALS
IBD (Posters)
et al.
SERUM LIPID AND C-REACTIVE PROTEIN LEVELS BY TREATMENT RESPONSE FOLLOWING 8 WEEKS OF TOFACITINIB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS
IBD (Posters)
et al.
Item 201 - 220 / 279
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Chat with us
, powered by
LiveChat